CHU de Limoges
Limoges, France
NCT Number: NCT00760331
Anomalies of renal development are well know for patients treated for MODY-5 diabetes due to TCF2 mutation.A recent study confirms the existence of pediatric patients having TCF2 mutation but presenting renal anomalies alone.Endocrine and renal evolution of these patients is unknown.The aim of this study is to follow a cohort of patients with TCF2 mutation and initially presenting renal anomalies alone.
This study is active but is not currently recruiting participants.
Notify MeUp to 18 year
All sexes
Observational
Limoges, France
Biologic analysis and renal ultrasonography once a year.
After puberty or before kidney transplantation
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University Hospital, Limoges
Other
A Long Term Follow up of a Cohort of Children With TCF2 Mutation:Evolution of Endocrine and Renal Function
Acronym: TCF2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07729566
CAKUT, Cakut
Sohag, Sohag Governorate, Egypt
View Trial DetailsNCT06921733
Cakut, Congenital Anomalies of Kidney and Urinary Tract
Erlangen, Bavaria, Germany
View Trial DetailsNCT06728007
Cakut, Congenital Abnormalities
Bologna, Italy
View Trial DetailsNCT04115345
Cakut, Chronic Disease
Atlanta, Georgia, United States
View Trial Details